Article
Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy.
Intervirology - 1 Jan 2014
Toyoda Hidenori, Kumada Takashi, Shimada Noritomo, Takaguchi Koichi, Ide Tatsuya, Sata Michio, Ginba Hiroyuki, Matsuyama Kazuhiro, Izumi Namiki
Abstract excerpt
OBJECTIVE: Some patients with chronic hepatitis C virus (HCV) infection fail to achieve complete early virologic response (EVR) despite a marked decrease in HCV RNA at 4 weeks. We investigated the characteristics and final treatment outcomes of this patient subpopulation. METHODS: A total of 516 patients with HCV genotype 1 were enrolled. Background characteristics and final outcomes were compared between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.